INDEX NAME NOT YET ASSIGNED
|
利格列汀杂质
|
2749405-42-1
|
(R)-1-Boc-3-Aminopiperidine
|
(R)-1-叔丁氧羰基-3-氨基哌啶(利奈唑胺杂质)
|
625471-18-3
|
Olmesartan Medoxomil Impurity F
|
奥美沙坦酯杂质F
|
1227626-51-8
|
Linagliptin Impurity S
|
利格列汀杂质S
|
668273-74-3
|
(Z)-1-(6-methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone oxime
|
依地昔布EP杂质D
|
1810761-43-3
|
Olmesartan Impurity 1
|
奥美沙坦杂质1
|
2411637-68-6
|
|
利格列汀进口标准杂质
|
2518331-40-1
|
(2S)-1-(2,2,2-trifluoroacetyl)pyrrolidine-2-carbonitrile; 2-Pyrrolidinecarbonitrile, 1-(trifluoroacetyl)-, (S)- (9CI)
|
维格列汀的杂质
|
151258-26-3
|
Etoricoxib Impurity H
|
依托考昔杂质H
|
646459-39-4
|
Linagliptin Impurity F
|
利格列汀杂质F
|
1673546-62-7
|
Linagliptin Impurity 51
|
利格列汀杂质51
|
2138392-83-1
|
Olmesartan Impurity 19
|
奥美沙坦酯杂质19
|
161952-66-5
|
tert-butyl (R)-(1-((4-methylquinazolin-2-yl)methyl)piperidin-3-yl)carbamate
|
利格列汀杂质C
|
2514949-81-4
|
5-[4'-(Bromomethyl)-[1,1'-biphenyl]-2-yl]-2-(triphenylmethyl)-2H-tetrazole
|
5-[4'-(溴甲基)-[1,1'-联苯]-2-基]-2-(三苯基甲基)-2H-四氮唑(奥美沙坦杂质15)
|
133051-88-4
|
4'-(Dibromomethyl)-[1,1'-Biphenyl]-2-Carbonitrile
|
2'-氰基-4-(二溴甲基)联苯(奥美沙坦酯杂质)
|
209911-63-7
|
Dehydro Olmesartan
|
脱氢奥美沙坦(奥美沙坦酯杂质)
|
172875-98-8
|
Linagliptin Impurity 24
|
利格列汀杂质24
|
1418133-47-7
|
vildagliptin Impurity V
|
维格列汀杂质V
|
1032564-18-3
|
Linagliptin iMpurity E
|
利拉利汀杂质E
|
1446263-38-2
|
Linagliptin Impurity 16
|
利格列汀杂质16
|
1791405-13-4
|
Etoricoxib Impurity O
|
依托考昔杂质O
|
307531-95-9
|
Linagliptin Impurity 29
|
利拉利汀杂质29
|
2074688-82-5
|
Etoricoxib Impurity 9
|
依托考昔杂质9
|
859824-65-0
|
Linagliptin impurity KH-3
|
利格列汀杂质
|
2279114-27-9
|
Olmesartan Medoxomil Impurity O
|
奥美沙坦酯杂质O
|
189400-21-3
|
Acetamide, N-(2-acetylphenyl)-2,2-dichloro-
|
利格列汀杂质
|
6140-12-1
|
Olmesartan Medoxomil EP Impurity C
|
奥美沙坦EP杂质C
|
879562-26-2
|
Olmesartan Medoxomil Methyl Ether
|
奥美沙坦酯甲基醚
|
896419-17-3
|
Linagliptin Impurity 35
|
利格列汀杂质35
|
668273-75-4
|
Etoricoxib impurity Q
|
依托考昔杂质Q
|
292067-97-1
|
Linagliptin impurity 16
|
利拉利汀杂质16
|
1955514-80-3
|
Olmesartan Impurity 51
|
奥美沙坦酯杂质51
|
1418133-29-5
|
Olmesartan Impurity G
|
5-(4-(二溴甲基)-[1,1-二联苯]-2-基)-1-三苯甲基-1H-四唑
(奥美沙坦酯杂质G)
|
358685-13-9
|
Vildagliptin Impurity ZA6
|
维格列汀杂质ZA6
|
2246354-69-6
|
Linagliptin Impurity 14
|
利格列汀杂质14
|
2416949-69-2
|
Vildagliptin Carboxylic Acid
|
维格列汀羧酸
|
565453-40-9
|
OlMesartan interMediate iMpurity II
|
奥美沙坦酯杂质6
|
144690-07-3
|
Olmesartan Medoxomil EP Impurity D
|
奥美沙坦酯 EP杂质D
|
1020157-01-0
|
Etoricoxib Impurity 8
|
依托考昔杂质 8
|
1421227-97-5
|
Etoricoxib Impurity 13
|
依托考昔杂质13
|
1817735-82-2
|
N-Phthalimide-linagliptin
|
N-邻苯二甲酰亚胺-利格列汀
|
886588-63-2
|
Olmesartan Medoxomil Impurity 26
|
奥美沙坦酯杂质26
|
1392475-91-0
|
Olmesartan Medoxomil Impurity 17
|
美沙坦酯杂质17
|
1418133-31-9
|
1H-Imidazole-4,5-dicarboxylic acid, 2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-
|
奥美沙坦酯杂质
|
1350442-05-5
|
INDEX NAME NOT YET ASSIGNED
|
利格列汀杂质
|
2748381-67-9
|
OlMesartan Lactone IMpurity
|
奥美沙坦内酯杂质
|
849206-43-5
|
2-Methyl-5-(3-(4-(Methylsulfonyl)phenyl)furan-2-yl)pyridine
|
依托考昔杂质P
|
307531-96-0
|
Etoricoxib Impurity 11
|
依托考昔去甲基杂质
|
202409-31-2
|
|
利格列汀进口标准杂质
|
216854-23-8
|
yl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]carbamoyl]benzoicacid
|
利格列汀进口标准杂质
|
2074688-81-4
|
Olmesartan Medoxomil Impurity 28
|
奥美沙坦酯杂质28
|
1127249-17-5
|
Olmesartan Impurity 8
|
奥美沙坦杂质8
|
157356-73-5
|
5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide
|
依托考昔 N-氧化物
|
325855-74-1
|
6'-DesMethyl-6'-carboxy Etoricoxib
|
依托考昔杂质L
|
349536-39-6
|
Vildagliptin Related Compound A
|
维格列汀杂质A
|
741657-02-3
|
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate
|
( 4-(2-羟异丙基)-2-丙基-1H-咪唑-5-甲酸(5-甲基-2-氧杂-1,3-二氧-4-甲基)酯(奥美沙坦酯杂质)
|
144978-05-2
|
Linagliptin N-Acetyl Impurity
|
利格列汀N-乙酰杂质
|
1803079-49-3
|
Linagliptin Impurity 33
|
利格列汀杂质33
|
2443735-53-1
|
Etoricoxib Impurity 18
|
依托考昔杂质18
|
1027162-35-1
|
Linagliptin Impurity 3
|
利格列汀杂质3
|
2749409-37-6
|
vildagliptin Impurity U
|
维格列汀杂质U
|
38074-72-5
|
Olmesartan Impurity 65
|
奥美沙坦杂质65
|
172875-53-5
|
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
|
利拉利汀母核
|
853029-57-9
|
Olmesartan Impurity 89
|
奥美沙坦杂质89
|
151052-34-5
|
Linagliptin iMpurity G
|
利拉利汀杂质G
|
668270-11-9
|
6'-DesMethyl-6'-Methylhydroxy Etoricoxib
|
依托考昔杂质K
|
349536-41-0
|
Linagliptin Impurity K
|
利格列汀杂质K
|
1638744-06-5
|
Etoricoxib Impurity 36
|
依托考昔杂质36
|
1798110-01-6
|
N-Depiperidin-3-amine Linagliptin Dimer
|
N-去哌啶-3-胺 利格列汀二聚体(利格列汀杂质)
|
2253964-98-4
|
Vildagliptin Carboxylic Acid Methyl Ester
|
维达列汀羧酸甲酯
|
948574-56-9
|
1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-(methylamino)-1-[(4-methyl-2-quinazolinyl)methyl]-
|
7-(丁-2-炔-1-基)-3-甲基-8-(甲基氨基)-1-((4-甲基喹唑啉-2-基)甲基)-1H-嘌呤-2,6-(3H,7H)-二酮(利格列汀杂质)
|
2468656-63-3
|
Etoricoxib Impurity
|
依托考昔进口标准杂质
|
2724840-93-9
|
INDEX NAME NOT YET ASSIGNED
|
利格列汀杂质
|
2748491-45-2
|
Vildagliptin Impurity 18
|
维格列汀杂质18
|
23500-10-9
|
4-(hidroximetil)-5-metil-1,3-dioxol-2-one
|
4-(羟甲基)-5-甲基-[1,3]二氧杂环戊烯-2-酮(奥美沙坦酯中间体)
|
91526-18-0
|
OlMesartan DiMer Ester IMpurity
|
奥美沙坦酯二聚体
|
1040250-19-8
|
Olmesartan Medoxomil Impurity 7
|
奥美沙坦酯杂质7
|
761404-85-7
|
2 - (ChloracetylaMino)acetophenon
|
利拉利汀杂质Q(利格列汀杂质)
|
6140-11-0
|
Linagliptin Impurity D
|
利格列汀杂质D
|
666816-91-7
|
Linagliptin Impurity H
|
利格列汀杂质H
|
1646355-34-1
|
5-(4'-(bromomethyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole
|
奥美沙坦酯杂质43
|
138402-33-2
|
Olmesartan Impurity 9
|
奥美沙坦酯杂质9
|
849206-42-4
|
Linagliptin Impurity 10
|
利格列汀杂质10
|
1911621-52-7
|
|
利格列汀进口标准杂质
|
2137744-33-1
|
Trityl olmesartan
|
三苯甲基奥美沙坦酯(奥美沙坦酯中间体)
|
144690-92-6
|
Olmesartan Medoxomil Impurity G
|
奥美沙坦MEDOXOMIL杂质G
|
761404-82-4
|
Linagliptin Impurity A
|
利格列汀杂质A
|
2436762-89-7
|
Etoricoxib Impurity 47
|
依托考昔杂质45
|
2241145-66-2
|
Linagliptin Impurity 45
|
利格列汀杂质45
|
2463617-43-6
|
Linagliptin impurity
|
利格列汀杂质
|
2444011-29-2
|
Vildagliptin Impurity
|
维格列汀杂质
|
565453-41-0
|
2-QuinazolineMethanol, 4-Methyl-
|
利拉利汀杂质N
|
13535-91-6
|
vildagliptin Impurity Isomer
|
维格列汀对映异构体
|
1036959-27-9
|
Vildagliptin iMpurity K
|
维格列汀杂质 K
|
565453-39-6
|
Olmesartan Impurity 38
|
奥美沙坦酯杂质38
|
1039762-39-4
|
Linagliptin Impurity 28
|
利格列汀杂质28
|
2074688-84-7
|
Linagliptin Impurity 20
|
利格列汀杂质20
|
2463617-49-2
|
Vildagliptin Impurity 13
|
维达列汀杂质13
|
2577-48-2
|
Linagliptin impurity KH-2
|
N-(2-乙酰基苯基)-2-(8-溴-7-(丁-2-炔-1-基)-3-甲基-2,6-二氧代-2,3,6,7-四氢-1H--嘌呤-1-基)乙酰胺(利格列汀杂质)
|
2279114-31-5
|
1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-[(4-methyl-2-quinazolinyl)methoxy]-1-[(4-methyl-2-quinazolinyl)methyl]-
|
利格列汀杂质
|
2469626-53-5
|